This test is most useful if any of these apply to you.
A blistering or raw sore on the vulva or vagina is almost always assumed to be herpes, and most of the time it is. In a few cases out of every hundred, though, the cause is VZV (varicella-zoster virus). That's the chickenpox virus, waking up in a nerve near the base of your spine.
Which virus it is changes what you do next. Genital shingles usually comes from virus you already carry, so a partner didn't give it to you. In people with healthy immune systems it usually happens once, and it needs higher antiviral doses than herpes does. A swab of the sore is how you find out which one you have.
The first time this virus infects you, it causes chickenpox. It spreads through droplets in the air or through contact with fluid from the blisters. After the rash heals, the virus travels up sensory nerves and settles in clusters of nerve cells beside the spinal cord, where it stays dormant for the rest of your life.
Your immune system keeps it in check through white blood cells called T cells. When that surveillance weakens with age, illness, or medication, the virus can reawaken and travel back down the same nerve to the skin it supplies, which is what shingles is. Some of the lowest nerves in the spine supply the vulva, vagina, cervix, groin, and the skin around the anus. When the virus reawakens in one of those, the sores show up there.
This swab looks for the virus in material taken from the genital tract. In a healthy state the virus isn't on that surface; it appears there only while it's replicating in the skin or lining. So the result is a yes or no about one moment: whether the virus is active at that spot right now. A swab can't reach the dormant virus in your nerves, so it says nothing about that.
Genital shingles and genital herpes produce blisters and raw sores that can look identical, and both can cause burning nerve pain. When labs test genital swabs for both viruses, the chickenpox virus turns up in a small share of positives, often when no one suspected it.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 6,210 genital swabs sent for viral testing | Which herpes-family virus turned up among the positive swabs | The chickenpox virus in about 3 of every 100 positives (2.9%), compared with 36% for herpes simplex type 1 and 61% for type 2 |
| 2,113 skin and genital swabs run on a combined herpes and chickenpox-virus test | Whether the chickenpox virus appeared in genital samples | 14 genital samples were positive, a result the lab had not expected |
| Sexually active women in Australia | Cervical swabs checked for a wide set of infections | The chickenpox virus turned up in a small share of cervical swabs, which the authors had not expected |
Sources: Birch et al.; Granato et al.; McIver et al.
The misdiagnosis runs both ways. In the largest study, many of the people who turned out to have the chickenpox virus had been presumed to have herpes before lab testing. In a large shingles vaccine trial, a small share of rashes that doctors called shingles tested positive for herpes simplex instead.
What this means for you: herpes simplex is still the far more common cause of a genital sore. If a sore is swabbed, though, make sure the sample is tested for both herpes simplex and the chickenpox virus. A swab tested for herpes alone will come back negative on genital shingles, and you may leave believing you had a false alarm, or a herpes infection the test somehow missed.
The two infections lead to very different conversations. Genital herpes is sexually transmitted, tends to recur, and can be shed silently between outbreaks. Genital shingles comes from virus you've carried since chickenpox, so it tells you nothing about a partner. In people with healthy immune systems shingles usually happens once, though roughly 1 in 10 people have another episode at some point.
Treatment differs too. Shingles needs higher antiviral doses than the regimens used for herpes, so a herpes-dose prescription can undertreat it. For many people the biggest change is emotional, since a shingles episode replaces what would otherwise have been a lifelong herpes label.
Two groups face higher stakes, though for different reasons. In pregnancy the main danger comes from a first infection: chickenpox while pregnant carries a risk of a pattern of birth defects called congenital varicella syndrome, and chickenpox around delivery can cause a severe, sometimes life-threatening infection in the newborn. Shingles in pregnancy, which is what a genital episode usually is, hasn't been linked to harm to the baby, because the antibodies you already have cross the placenta. It still calls for prompt contact with your obstetrician, especially close to delivery.
If your immune system is suppressed, the virus can escape the nerve it started in and spread to internal organs, and sometimes to the brain and spinal cord. Among people admitted to intensive care with severe infection, death rates were high and depended more on how suppressed their immune systems were than on which organ was involved. These spread-out cases are often misdiagnosed at first, and survival improves when antivirals start early.
Pooled studies of shingles risk point to the same groups: older age, cancer, diabetes, immune-suppressing treatment, physical trauma, and a family history of shingles all raise the odds, and organ transplantation carries the highest risk of the conditions studied. If any of these apply to you, a genital episode deserves prompt treatment, ideally starting the day it's confirmed.
The findings in this section come from studies of shingles anywhere on the body, so they apply to a genital episode by extension. Large reviews pooling many studies find that a shingles episode is followed by a higher risk of stroke and heart events, with stroke the most consistent link, and the stroke link is strongest in younger people. A large population study linked shingles to more heart attacks and episodes of unstable chest pain. These are observational links, so they show the two travel together without proving the shingles caused the events.
Carrying the virus quietly looks different. Among several thousand adults in the UK Biobank, a large British health study, having antibodies to herpes-family viruses, this one included, wasn't linked to stroke, heart attack, or death.
Those two results fit together once you separate the dormant virus from an active episode. Antibodies show only that the virus lives somewhere in you, which is true for a large share of adults and doesn't track with risk. A reactivation is a distinct event, and that event is what the studies tie to vascular problems. A positive swab marks one of those events.
A 2026 review pooling the available studies also linked infection with this virus to a higher risk of Alzheimer's disease, an association that doesn't yet show cause and effect.
Labs detect this virus in several ways, and the method changes how much a negative result is worth. Check your report or ask your lab which method was used, because results from different methods can't be compared directly.
DNA-based tests are the standard. The most common one is called PCR, and it copies tiny amounts of viral DNA until there's enough to detect. On lesion swabs, these tests caught nearly every true case in validation studies with very few false positives.
Older methods miss far more, and current lab guidance no longer recommends them for diagnosis. In studies of skin and mucosal sores, growing the virus in a lab dish caught only 26% to 53% of cases, partly because it grows slowly and labs often stop watching before it shows. Staining cells with fluorescent antibodies caught 55% to 80%, and an old smear test caught 60% to 79% while being unable to tell this virus from herpes simplex at all. A newer rapid DNA method built for clinic use caught most but not all cases in children's chickenpox sores, with no false positives.
What this means for you: a negative from anything other than a standard DNA-based test doesn't rule this virus out, and if the sore still fits, it's worth swabbing again with a DNA test.
This test gives a yes-or-no answer, so there's no level to interpret. What can go wrong is a negative that should have been positive, and occasionally the reverse.
Rarely, contamination inside the lab produces a false positive, which is why labs run blank control samples alongside patient samples.
This isn't a number you trend. The virus is either active at the sampled spot or it isn't, and between episodes a swab will be negative whatever your future risk happens to be.
Retesting makes sense in three situations. Swab again if a negative came from a sore that was already crusting and the picture still fits. Swab any new sore, since a second genital episode can have a different cause than the first. And because repeat episodes are uncommon in people with healthy immune systems, a second confirmed episode is worth a closer look at what might be weakening your defenses.
The thing worth tracking over time is your immunity, which a blood antibody test shows, along with your vaccination status. That matters most before pregnancy and before starting immune-suppressing treatment.
Read the swab alongside what you can see and feel. These are the patterns that should drive your next step.
Varicella-Zoster Virus (VZV) is best interpreted alongside these tests.
Varicella-Zoster Virus (VZV) is included in these pre-built panels.